Navigation Links
United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
Date:2/27/2013

Philadelphia, PA (PRWEB) February 27, 2013

Wysebridge Patent Bar Review, the rapidly growing provider of study materials and resources for the Patent Bar Exam, responds to the USPTO announcement requiring test-takers to sign non disclosure agreements prior to the exam. This change will also be implemented on April 2nd, adding to the already major overhaul of the exam itself.

According the the USPTO, "Anyone taking the registration examination is expressly prohibited from disclosing, publishing, reproducing, or transmitting the content, or substantially similar content, of the examination, in whole or in part, in any form or by any means, verbal or written, electronic or mechanical, for any purpose. Beginning April 2, 2013, at each test site, every applicant will be required to enter into a non-disclosure agreement as a condition to sitting for the examination. Applicants should expect to encounter the following text on a computer screen at the examination."

What this means, is starting April 2nd, 2013 in order to take the test, individuals will have to sign a document that expressly prevents each and every test-taker from "transmitting" anything, anything, pertaining to the exam or content of the exam. Transmitting could be in the form of verbal, written, electronic. Thus, discussions about the exam, or material seen, or questions showing up on the exam, will be expressly forbidden and if performed, could bear legal repercussions.

For many, these types of discussions about past questions and material being tested have been the cornerstone of studying online. Come April, this invaluable study resource could disappear, leaving future test-takers at a severe disadvantage. Instead of having access to samples of questions being asked on actual exams, test-takers will be forced to rely on other means to study for the patent bar.

The below is a sample of what the NDA could look like starting April 2nd on the Patent Bar Exam:

NON-DISCLOSURE AGREEMENT AND GENERAL TERMS OF USE FOR EXAMS DEVELOPED FOR THE OFFICE OF ENROLLMENT AND DISCIPLINE OF THE UNITED STATES PATENT AND TRADEMARK OFFICE

This exam is confidential and proprietary. It is made available to you, the examinee, solely for the purpose of assessing your proficiency level in the skill area referenced in the title of this exam. You are expressly prohibited from disclosing, publishing, reproducing, or transmitting the content, or substantially similar content, of this exam, in whole or in part, in any form or by any means, verbal or written, electronic or mechanical, for any purpose. By clicking “Yes” below, you agree not to disclose, publish, reproduce, or transmit the content, or substantially similar content, of this exam, in whole or in part, in any form or by any means, verbal or written, electronic or mechanical, for any purpose.
o Yes, “I have read and agree to the terms stated above.”
o No, “I Do Not Agree.”

As stated, if a test-taker does NOT agree to this, they will be prevented from actually taking the exam.

In summary, this additional change will further alter the landscape of study materials for the Patent Bar Exam come April, and could result in the USPTO taking legal action against offenders. Test-takers will want to be aware of the potential ramifications of discussing material online, especially post-April.    

You can follow Wysebridge Patent Bar Review using a variety of social media sites, including Twitter, Facebook, and LinkedIn Stay updated on the latest tips, study suggestions, exam changes, and intellectual property updates.

About Wysebridge Patent Bar Review
Wysebridge Patent Bar Review is an information and educational company formed in 2012 dedicated to assisting individuals study for and pass the patent bar exam.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10465967.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Animal Husbandry Equipment Market in United States: Business Report 2011
2. Strategic Analysis of the Collagen Peptide Market in the United States
3. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
4. United Therapeutics Announces Additional $100 Million Share Repurchase Program
5. United States Rocket Academy Welcomes XCOR Aerospace to Texas
6. United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012
7. New Approach to Growing Waste to Value Industry in United States
8. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
9. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
10. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
11. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):